Europe — EMA
Moxonidine Biogaran
GNH USA supplies Moxonidine Biogaran (Moxonidine), a imidazoline receptor agonist for hypertension. Request a quote for global supply.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Moxonidine Biogaran, is an imidazoline receptor agonist presented as a tablet for oral use. It treats hypertension in adult patients.
GNH USA supplies Moxonidine Biogaran as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Moxonidine used for?
Moxonidine is used to lower elevated blood pressure in the hypertension therapeutic area.
Hypertension: reduces systolic and diastolic blood pressure in adults with primary hypertension. Essential hypertension: helps achieve target blood pressure levels when used as part of a comprehensive antihypertensive regimen. High blood pressure: contributes to cardiovascular risk reduction by maintaining controlled blood pressure.
What are the side effects of Moxonidine?
Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Dry mouth - Fatigue - Dizziness - Headache - Nausea - Constipation
Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reactions (rash, angioedema) - Elevated liver enzymes - Syncope - Skin eruptions
What precautions apply to Moxonidine?
When prescribing Moxonidine, clinicians should consider several safety aspects.
Renal impairment: dose adjustment may be required in patients with reduced kidney function. Hepatic impairment: monitor liver function tests and adjust therapy if needed. Elderly: initiate therapy at the lowest dose and titrate cautiously. Pregnancy: safety is unknown; avoid unless the benefit outweighs the risk. Concomitant antihypertensives: monitor blood pressure closely to prevent excessive hypotension. Store at ambient temperature: keep in the original pack, protect from moisture.
What does Moxonidine interact with?
Moxonidine can interact with other medicines, influencing its efficacy or safety.
Major Interactions (Avoid): - Combined use with other central antihypertensives (e.g., clonidine) may cause excessive hypotension. - Strong CYP2D6 inhibitors may increase plasma concentrations of moxonidine.
Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs may attenuate the antihypertensive effect. - Diuretics may potentiate hypotensive response. - Alcohol consumption can increase dizziness and sedation.
